Before the first Pradaxa (dabigatran) product liability case went to trail, Boehringer Ingelheim Pharmaceuticals Inc. reached a comprehensive $650 million settlement of federal and state product liability suits.
In a May 28 release, the company said it seeks to resolve approximately 4,000 claims with the settlement and that...